CHINA’S PHARMA HOLDINGS INC SHOWCASES COSTS OF LAX QUALITY CONTROL

China Pharma Holdings Inc. has suffered a third quarter blowout as a result of new GMP standards for quality control. The company is listed on the NYSE with a fully integrated specialty subsidiary operating in China.